Schedule of investment in associates (Details) - Alps Life Science Inc [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| IfrsStatementLineItems [Line Items] | ||
| Unquoted shares - at cost beginning | $ 1,493,850 | $ 895 |
| Addition during the financial year | 1,492,955 | |
| Unquoted shares - at cost end | 1,493,850 | 1,493,850 |
| Accumulated impairment loss beginning | (257) | (257) |
| Addition during the financial year | ||
| Accumulated impairment loss ending | (257) | (257) |
| Unquoted shares- at cost, net | 1,493,593 | 1,493,593 |
| Share of post acquisition reserve beginning | 13,911 | 10,490 |
| Share of (loss)/profit during the financial year | (10,760) | 3,421 |
| Share of post acquisition reserve ending | 3,151 | 13,911 |
| Share of post- acquisition reserve, net | 1,496,744 | 1,507,504 |
| Exchange differences | 99,432 | (860) |
| Investment in associates | $ 1,596,176 | $ 1,506,644 |